Kalbe Farma Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 197.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 96.7K). Which is the better fit depends on your goals.
| KLBF | OBAT | |
|---|---|---|
Market Cap | 33T | 167.37B |
Volume | 98.44M | 96.7K |
Lot | 984.38K | 967 |
Turnover | 70.64B | 23.82M |
Average Price | 717.58 | 246.34 |
Value | 70.64B | 23.82M |
Indicative Equilibrium Price | 720 | 248 |
Indicative Equilibrium Volume | 43.62K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →